Consolidated Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from Operating Activities
Net Loss	$ (1,032,951)	$ (78,377)
Adjustments to Reconcile Net Loss to Net Cash Provided by (Used in) Operating Activities
Stock based compensation	210,741	0
Bad debt expense (recovery)	(73,895)	0
Change in fair market value of warrant liability	311,400	0
Depreciation and amortization	100,109	2,173
Changes in Assets and Liabilities
(Increase) decrease in accounts receivable	(335,766)	965,883
Decrease (increase) in inventories	45,880	(21,452)
Decrease (increase) in vendor deposits	8,767	(126,350)
(Increase) in prepaid expenses	(486,997)	(52,351)
(Decrease) in accounts payable and accrued expenses	(141,729)	(78,103)
(Decrease) increase in deferred revenue	(178,732)	202,006
Total Adjustments	(540,222)	891,806
Net Cash Provided by (Used in) Operating Activities	(1,573,173)	813,429
Cash Flows From Investing Activities
Cash paid for patent costs	(14,435)	0
Purchase of machinery and equipment	0	(98,244)
Cash paid for acquisition; net of cash acquired	(760,293)	0
Note receivable, related party	(500,000)	0
Net Cash Used in Investing Activities	(1,274,728)	(98,244)
Cash Flows From Financing Activities
Payments on capital leases	(1,594)	0
Proceeds from warrant exercise	1,157	0
Loan from (to) officer	0	(32,734)
Net Cash (Used In) Financing Activities	(437)	(32,734)
Net Increase in Cash and equivalents	(2,848,338)	682,451
Cash and equivalents at January 1,	11,757,930	1,029,936
Cash and equivalents at March 31,	8,909,592	1,712,387
Cash paid during the year for:
Interest	573	0
Supplemental Non-Cash Items
Initial recognition of warrant liability	135,125	0
Reclassification from liability to be settled in stock to additional paid in capital	21,420	0
Fair market value of stock granted in connection with acquisition	$ 7,122,500	$ 0